Select Page

The first lawsuits against the companies behind Xarelto – a blood thinning medication manufactured by Bayer and marketed by Janssen Pharmaceuticals – have been filed in a United States court.

The claims were filed after patients who took Xarelto experienced severe interal bleeding which resulted in hospital treatment. The excessive bleeding is the result, plaintiffs claim, of the use of the drug.

The medication, at this point, has no antidote to stop the uncontrolled, life-threatening bleeding. Other popular blood thinners do have such an antidote.

One of the lawsuits against xarelto was filed by Kentucky’s Virginia Stunteneck. Stunteneck experienced severe gastrointestinal bleeding in 2013 after taking Xarelto. The lawsuit was filed in the U.S. District Court of the Eastern District of Pennsylvania.

The main claim of the Xarelto lawsuit is that the medication should not have been sold, given the risks, yet continued to be pushed by Bayer and Janssen (a division of Johnson & Johnson) despite the companies knowing about the risks. Furthermore, the suit claims the companies did not inform the public adequately of those risks.

In 2010 another drug for blood thinning, Pradaxa, was released with similar bleeding side effects. In May of this year the company behind the drug paid $650 million to settle thousands of similar lawsuits. Pradaxe was released one year before Xarelto.

Update: Summer 2016 – If you or a loved one have suffered devastating side effects as the result of taking Xarelto, you may be entitled to compensation. The lawsuits are currently in the Discover process where both sides are exchanging information. To see if your case qualifies please contact a lawyer that is experienced with this particular case – click here to learn more.

Save

Save